Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
Anne Wojcicki ... private is its "the best path forward." Wojcicki, who this spring said she wanted to take 23andMe Holding Co. (Nasdaq: ME) private and wouldn't consider a third-party officer ...
San Francisco Chronicle on MSN1mon
23andMe CEO Anne Wojcicki ‘surprised and disappointed’ by mass board resignationAnne Wojcicki, CEO and co-founder of 23andMe, said she was “surprised and disappointed” following the abrupt resignation of ...
Though 23andMe says the restructuring plan will cost it around $12 million, it expects to save more than $35 million as a ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The firm expects to save more than $35 million in annualized costs through the restructuring. CEO Anne Wojcicki told ...
Wojcicki's buzzy health-tech startup saw its stock value drop to below $1 in recent months. Anne Wojcicki wants to take 23andMe private. On Wednesday, Wojcicki, CEO and co-founder of the San ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback